HRT Financial
SNTI icon

HRT Financial’s Senti Biosciences Holdings SNTI Stock Holding History

HRT Financial’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$16K Buy
+53,827
New +$24.8K ﹤0.01% 4529
2026
Q2 		– Sell
-14,844
Closed -$12K – 5259
2026
Q1 		$12K Buy
+14,844
New +$14.4K ﹤0.01% 3621
2024
Q3 		– Sell
-1,251
Closed -$3K – 3080
2024
Q2 		$3K Buy
+1,251
New +$4.05K ﹤0.01% 2068
2022
Q2 		– Sell
-2,938
Closed -$290K – 3672
2022
Q1 		$290K Sell
2,938
-196
-6% -$19.3K ﹤0.01% 2258
2021
Q4 		$309K Buy
+3,134
New +$312K ﹤0.01% 2251

Other funds holding SNTI

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
Menlo Ventures Management
Menlo Ventures Management Menlo Park, California $241M AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

HRT Financial's SNTI Position: Q3 2026 in Review

HRT Financial opened a new position in Senti Biosciences Holdings (SNTI) in Q3 2026: 53,827 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #4529 among its holdings. This is a return to the name: HRT Financial previously reported a position in SNTI as recently as Q1 2026.

HRT Financial first reported a position in SNTI in Q4 2021 and has held it in 5 quarters since. The position peaked at $309K in Q4 2021. 13 funds tracked by Wall St. Rank hold SNTI as of Q3 2026.

  • HRT Financial held 53,827 shares of Senti Biosciences Holdings worth $16K as of Q3 2026.
  • Senti Biosciences Holdings was a new HRT Financial position in Q3 2026.
  • Senti Biosciences Holdings made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #4529 holding.
  • HRT Financial first reported a position in Senti Biosciences Holdings in Q4 2021 and has held it in 5 quarters since.
  • HRT Financial's Senti Biosciences Holdings position peaked at $309K in Q4 2021.
  • 13 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.